{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04032847",
            "orgStudyIdInfo": {
                "id": "ATX-NS-001"
            },
            "organization": {
                "fullName": "Achilles Therapeutics UK Limited",
                "class": "INDUSTRY"
            },
            "briefTitle": "ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC",
            "officialTitle": "An Open-Label, Multi-Centre Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T Cells in Patients With Advanced Non-Small Cell Lung Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "in-patients-with-advanced-unresectable-or-metastatic-nsclc"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-07-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-07-17",
            "studyFirstSubmitQcDate": "2019-07-22",
            "studyFirstPostDateStruct": {
                "date": "2019-07-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Achilles Therapeutics UK Limited",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a first-in-human, open-label, multi-centre, phase I/IIa study to characterise the safety and clinical activity autologous clonal neoantigen reactive T cells (cNeT) administered intravenously in adults with advanced non-small cell lung cancer (NSCLC).",
            "detailedDescription": "This is a first-in-human, open-label, multi-centre, phase I/IIa study to characterise the safety and clinical activity of autologous clonal neoantigen reactive T cells (cNeT) administered intravenously in adults with advanced non-small cell lung cancer (NSCLC).\n\nPatients will initially enter the study for procurement of tumour materials required to manufacture ATL001.\n\nFollowing manufacture of ATL001, the product will be given back to eligible patients following lymphodepletion. Patients will continue to be followed up for a minimum of 5 years, as part of a separate Long Term Follow Up Protocol, or, if the separate protocol is not available at the study site, within this protocol."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Non Small Cell Lung Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort A",
                    "type": "EXPERIMENTAL",
                    "description": "Following lymphodepletion with enhanced host conditioning, infusion of cell therapy product ATL001, followed by a low dose regimen of IL- 2.",
                    "interventionNames": [
                        "Biological: ATL001"
                    ]
                },
                {
                    "label": "Cohort B",
                    "type": "EXPERIMENTAL",
                    "description": "Following lymphodepletion with enhanced host conditioning, infusion of cell therapy product ATL001 in combination with a checkpoint inhibitor, followed by a low dose regimen of IL- 2.",
                    "interventionNames": [
                        "Biological: ATL001",
                        "Drug: Pembrolizumab"
                    ]
                },
                {
                    "label": "Cohort C",
                    "type": "EXPERIMENTAL",
                    "description": "Following lymphodepletion with enhanced host conditioning, infusion of cell therapy product ATL001, followed by a higher dose regimen of IL-2.",
                    "interventionNames": [
                        "Biological: ATL001"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "ATL001",
                    "description": "ATL001 infusion",
                    "armGroupLabels": [
                        "Cohort A",
                        "Cohort B",
                        "Cohort C"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pembrolizumab",
                    "description": "Checkpoint inhibitor",
                    "armGroupLabels": [
                        "Cohort B"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Assessment of Treatment Emergent Adverse Events (TEAEs) to evaluate Safety and Tolerability",
                    "description": "Evaluate TEAEs and serious AEs, by incidence, severity and relationship to ATL001",
                    "timeFrame": "84 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Disease Assessment for Change from Baseline in Tumour Size",
                    "description": "Evaluate the clinical activity of ATL001 in patients with advanced NSCLC using change from baseline in tumour size at week 6 , week 12 and best overall change from baseline, as assessed by investigator and independent central review (ICR)",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Disease Assessment for Objective Response Rate (ORR)",
                    "description": "Evaluate the endpoint of ORR as assessed by investigator and ICR, per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 and immune modified RECIST( im-RECIST).",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                },
                {
                    "measure": "Disease Assessment for Time to Response (TTR) from ATL001 infusion",
                    "description": "Evaluate the endpoint of TTR by the investigator and ICR, per RECIST v1.1 and im-RECIST",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                },
                {
                    "measure": "Disease Assessment for Duration of Response (DoR). The DoR is defined as the time from the date of first documented response until the date of documented disease progression or death",
                    "description": "Evaluate the endpoint of DOR by the investigator and ICR, per RECIST v1.1 and im-RECIST",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                },
                {
                    "measure": "Disease Assessment for Disease Control Rate (DCR)",
                    "description": "Evaluate the endpoints of DCR as assessed by the investigator and ICR per RECIST v1.1 and im-RECIST",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                },
                {
                    "measure": "Disease Assessment for Progression-Free Survival (PFS)",
                    "description": "Evaluate the efficacy endpoints of PFS as assessed by the investigator and ICR per RECIST v1.1 and im-RECIST",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "Evaluate OS by the investigator",
                    "timeFrame": "Every 6 weeks for 6 months, then every 3 months for a maximum of 84 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patient must be at 18-75 years old.\n2. Patients must have confirmed diagnosis of non-small cell lung cancer that is considered to be smoking related.\n3. Patient is considered medically fit to undergo procurement of starting material and ATL001 administration procedures.\n4. ECOG Performance Status 0-1.\n5. Adequate organ function per the laboratory parameters defined in the protocol.\n6. Anticipated life expectancy \u2265 6 months at the time of tissue procurement.\n7. Measurable disease according to RECIST 1.1 criteria.\n\nAdditional Inclusion Criteria will apply as per the protocol.\n\nExclusion Criteria:\n\n1. Patients with untreated, symptomatic or progressing CNS metastases. Lesions should be clinically and radiologically stable for 2 months after treatment and should not require steroids.\n2. Patients with hepatitis B or C, human immunodeficiency virus infection (HIV1/2), syphilis or HTLVI/II infection.\n3. Patients for whom there is documented evidence of an actionable tumour driver oncogene mutation (EGFR, ALK or ROS-1) at the time of initial screening. Patients who have progressed on standard targeted therapies, or for whom no approved targeted treatments are available, are not excluded.\n4. Patients requiring immunosuppressive treatments.\n5. Patients requiring regular steroids at dose higher than prednisolone 10mg/day (or equivalent)\n6. Patients with superior vena cava syndrome.\n7. Patients with clinically significant, progressive, and/or uncontrolled renal, hepatic, haematological, endocrine, pulmonary, cardiac, gastroenterological or neurological disease.\n8. Patients with a history of immune mediated central nervous system toxicity, or a history of \u2265 Grade 2 diarrhoea/colitis within the past 6 months caused by previous immunotherapy.\n9. Patients with an active concurrent cancer or a history of cancer within the past 3 years (except for in situ carcinomas, early prostate cancer with normal Prostate- Specific Antigen (PSA) or non-melanomatous skin cancers)\n10. Patients with a history of organ transplantation\n11. Patients who have previously received any investigational cell or gene therapies\n\nAdditional Exclusion Criteria will apply as per the protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Achilles Therapeutics UK Limited",
                    "role": "CONTACT",
                    "phone": "+44 (0)20 8154 4600",
                    "email": "Clinical.info@achillestx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Monitor, MD",
                    "affiliation": "Achilles Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Yale University School of Medicine",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10017",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke University Medical Center",
                    "status": "WITHDRAWN",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Centre Hospitalier Lyon Sud",
                    "status": "RECRUITING",
                    "city": "Pierre-B\u00e9nite",
                    "zip": "69310",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Carl Gustav Carus Dresden",
                    "status": "RECRUITING",
                    "city": "Dresden",
                    "zip": "01307",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.05089,
                        "lon": 13.73832
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Essen",
                    "status": "RECRUITING",
                    "city": "Essen",
                    "zip": "45147",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Hospital Clinic de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "state": "Catalonia",
                    "zip": "08036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jimenez D\u00edaz",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Centro Integral Oncologico Clara Campal Hospital Universitario HM Sanchinarro",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28050",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Clinico Universitario de Valencia",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46010",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "zip": "B15 2GW",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.48142,
                        "lon": -1.89983
                    }
                },
                {
                    "facility": "Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital",
                    "status": "RECRUITING",
                    "city": "Cambridge",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "The Leeds Teaching Hospitals NHS Trust, St James's University Hospital",
                    "status": "RECRUITING",
                    "city": "Leeds",
                    "zip": "LS9 7TF",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.79648,
                        "lon": -1.54785
                    }
                },
                {
                    "facility": "University College London Hospitals (UCLH) NHS Foundation Trust, University College Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW1 2PG",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Guys and St Thomas' NHS Foundation Trust, Guy's Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "SE19RT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "The Christie NHS Foundation Trust, Christie Hospital",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M20 4BX",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "Manchester University NHS Foundation Trust, Wythenshawe Hospital",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M23 9LT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital",
                    "status": "RECRUITING",
                    "city": "Newcastle Upon Tyne",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 54.97328,
                        "lon": -1.61396
                    }
                },
                {
                    "facility": "University Hospital Southampton NHS Foundation Trust, Southampton General Hospital",
                    "status": "RECRUITING",
                    "city": "Southampton",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 50.90395,
                        "lon": -1.40428
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}